Disease
|
Drug/Important Bio-Agent (IBA)
2 | Mitochondrial Permeability Transition PoreIBA
08/2011
-
08/2009 |
2 | ZincIBA
07/2010
-
08/2009 |
2 | Adenosine (Adenocard)FDA LinkGeneric
07/2010
-
11/2009 |
2 | Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA
07/2010
-
11/2009 |
2 | Retinaldehyde (Retinal)IBA
05/2005
-
01/2005 |
1 | SolutionsIBA
08/2011 |
1 | 1-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA
08/2011 |
1 | diethylstilbestrol monophosphate (PDES)IBA
08/2011 |
1 | Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
08/2011 |
1 | N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA
07/2010 |
1 | Chelating AgentsIBA
07/2010 |
1 | ethylenediamine (ethylenediamine dihydroiodide)FDA Link
07/2010 |
1 | N- (4- acetylphenyl)- 2- (4- (2,3,6,7- tetrahydro- 2,6- dioxo- 1,3- dipropyl- 1H- purin- 8- yl)phenoxy)acetamideIBA
11/2009 |
1 | 2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA
11/2009 |
1 | BAY 60-6583IBA
11/2009 |
1 | 5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
11/2009 |
1 | Glycogen Synthase (Synthase I)IBA
08/2009 |
1 | Phosphotransferases (Kinase)IBA
08/2009 |
1 | Indicators and Reagents (Reagents)IBA
01/2005 |
1 | CholesterolIBA
01/2005 |
|
Therapy/Procedure
|